How do SCFAs trigger GLP-1 release
Moreover, a holistic and personalized approach (considering genomics) can address all the comorbidities to improve and optimize overall health outcomes in CKD
de Witte CJ, Espejo Valle-Inclan J, Hami N, Lohmussaar K, Kopper O, Vreuls CPH, et al
The easy one-tablet daily dosage makes it a convenient addition to a healthy routine
Dupont A, Heinbockel L, Brandenburg K, Hornef MW (2014) Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa
2729 Furthermore, strategies targeting the modulation of the gut microbiota (eg, probiotics and fecal microbiota transplantation) as well as exogenous supplementation with SCFAs have been widely proposed as potential therapeutic approaches, offering new avenues for mechanism-based interventions